Notice of interim decisions on proposed amendments to the Poisons Standard - ACMS and Joint ACMS-ACCS meetings, June 2020

This consultation closed on 13 October 2020.

1 Notice of interim decisions made under Regulation 42ZCZN of the Therapeutic Goods Regulations 1990

This web publication constitutes a notice for the purposes of regulation 42ZCZP of the Therapeutic Goods Regulations 1990 (the Regulations). In accordance with regulation 42ZCZP, this notice sets out:

• the interim decisions made by a delegate of the Secretary under regulation 42ZCZN in relation to proposed amendments to the current Poisons Standard which were referred to an expert advisory committee under subdivision 3D.2 of the Regulations in June 2020;
• the proposed date of effect of the proposed amendments (in circumstances where the interim decision proposes an amendment to the current Poisons Standard).

In accordance with regulation 42ZCZP, interested persons (including the applicant requesting the amendment) are invited to make submissions to the Secretary in relation to these interim decisions on or before 13 October 2020.

Please note that in accordance with subregulation 42ZCZQ(4) of the Regulations, the Secretary must publish all relevant submissions received, unless the Secretary considers the information to be confidential information.

How to respond

We have changed the way to make submissions.

Go to our consultation page to make a submission about these proposals to amend the Poisons Standard.

If you have difficulty accessing the consultation hub or uploading your submission, contact medicines.scheduling@health.gov.au and include 'Proposed Amendments to the Poisons Standard (Medicines)' or 'Proposed Amendments to the Poisons Standard (Chemicals)' in the subject line of the email.

2 Interim decision in relation to nicotine

Note that the interim decision on nicotine is not published in this notice. Publication is planned for 23 September 2020.

3 Interim decisions on proposed amendments referred to the Advisory Committee on Medicines Scheduling (ACMS #31, June 2020)

• 3.1 Interim decision in relation to oxymetazoline
• 3.2 Interim decision in relation to eletriptan
• 3.3 Interim decision in relation to clotrimazole
• 3.4 Interim decision in relation to sildenafil
• 3.5 Interim decision in relation to ibuprofen
• 3.6 Interim decision in relation to cumyl-pegaclone

4 Interim decisions on proposed amendments referred to the Advisory Committee on Medicines and Chemicals Scheduling in joint session (Joint ACMS-ACCS #25, June 2020)

• 4.1 Interim decision in relation to cannabidiol (private application) and cannabidiol (delegate initiated)
• 4.2 Interim decision in relation to isothiazolinones, methylisothiazolinone and methylchloroisothiazolinones